Kling Douglas F (CIK 1699022) reported 34 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-07-17). Recent activity: Buy NAMS (47,569 shares), Sell NAMS (44,025 shares), Sell NAMS (3,544 shares), Buy NAMS (51,043 shares), Sell NAMS (51,043 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-07-17 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Operating Officer | Buy | 47,569 | $518,502 |
| 2025-07-17 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Operating Officer | Sell | 44,025 | $941,254 |
| 2025-07-17 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Operating Officer | Sell | 3,544 | $78,393 |
| 2025-07-17 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Operating Officer | Buy | 51,043 | $556,369 |
| 2025-07-17 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Operating Officer | Sell | 51,043 | $1.1M |
| 2025-06-18 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Operating Officer | Buy | 78,101 | $781,010 |
| 2025-06-18 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Operating Officer | Buy | 21,899 | $238,699 |
| 2025-06-18 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Operating Officer | Sell | 81,891 | $1.6M |
| 2025-06-18 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Operating Officer | Sell | 18,109 | $357,653 |
| 2025-05-19 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Operating Officer | Buy | 100,000 | $1.0M |
| 2025-05-19 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Operating Officer | Sell | 100,000 | $0 |
| 2025-04-17 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Operating Officer | Sell | 99,090 | $0 |
| 2025-04-17 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Operating Officer | Buy | 100,000 | $1.0M |
| 2025-04-17 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Operating Officer | Sell | 910 | $0 |
| 2025-03-28 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Operating Officer | Buy | 16,539 | $0 |
| 2025-03-28 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Operating Officer | Sell | 16,539 | $0 |
| 2025-03-19 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Operating Officer | Buy | 88,112 | $0 |
| 2025-03-19 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Operating Officer | Buy | 11,888 | $118,880 |
| 2025-03-19 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Operating Officer | Sell | 100,000 | $0 |
| 2025-02-20 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Operating Officer | Buy | 90,782 | $0 |
| 2025-02-20 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Operating Officer | Sell | 90,782 | $0 |
| 2025-02-20 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Operating Officer | Buy | 9,218 | $0 |
| 2025-02-20 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Operating Officer | Sell | 9,218 | $0 |
| 2025-01-31 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Operating Officer | Buy | 56,863 | $0 |
| 2025-01-31 | NewAmsterdam Pharma Co N.V. (NAMS) | Chief Operating Officer | Sell | 56,863 | $0 |
Source: SEC Form 4 filings · as of 2025-07-17